SK Bioscience has signed a joint sales contract with GSK for five vaccines.

SK Bioscience announced on the 6th that it has signed a co-promotion contract for major vaccines with GSK to expand the domestic vaccine market. This is the content that SK Biosciences jointly sells and distributes vaccines developed by GSK in Korea.

These products are ▲Tdap (tetanus, diphtheria, pertussis) vaccine Boostrix ▲ meningococcal vaccine Menveo ▲ hepatitis A vaccine Havrix1440 ▲ (measles, parotitis, rubella) vaccine Priorix ▲ cervical cancer vaccine Cervarix.

Based on its domestic sales network, SK Bioscience is in charge of sales of Boostrix, Menveo, Havrix1440, and Priorix in the a